SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-003554
Filing Date
2023-01-06
Accepted
2023-01-06 16:16:06
Documents
15
Period of Report
2023-01-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d426017d8k.htm   iXBRL 8-K 29168
2 EX-99.1 d426017dex991.htm EX-99.1 15497
6 GRAPHIC g426017g0106011033298.jpg GRAPHIC 631
7 GRAPHIC g426017g47f13.jpg GRAPHIC 3703
  Complete submission text file 0001193125-23-003554.txt   180838

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA alny-20230105.xsd EX-101.SCH 2849
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE alny-20230105_lab.xml EX-101.LAB 17993
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alny-20230105_pre.xml EX-101.PRE 11260
9 EXTRACTED XBRL INSTANCE DOCUMENT d426017d8k_htm.xml XML 3434
Mailing Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36407 | Film No.: 23515271
SIC: 2834 Pharmaceutical Preparations